Why are my arms fatter than my body
Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment)
Clinical trial registries such as ClinicalTrials.gov also provide searchable records for ongoing and completed studies involving GLP-1 related compounds
The sub-study was designed to assess the effects of tirzepatide on blood pressure levels as measured by 24-hour ambulatory blood pressure monitoring in people with obesity but without Type 2 diabetes
Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, et al
Always consult with a qualified healthcare provider before making decisions about weight loss medications or treatment plans